Background Erythropoiesis‐stimulating agents (ESAs) are commonly used to treat anaemia
in people with chronic kidney disease (CKD). However, their use has been associated with …

The existing trials have focused on a variety of interventions to improve outcomes in renal
failure; however, quantitative evidence comparing the effect of performing multidimensional …

Background and aims Heart failure and chronic kidney disease (CKD) are closely linked,
with iron deficiency being highly prevalent in both conditions. Yet, major cardiovascular and …

Purpose To determine the effectiveness of pharmacy consultation in managing epoetin alfa-
epbx dosing for inpatients on hemodialysis. Methods This multisite, retrospective cohort …

Anemia comprises various causative factors such as traumatic blood loss, insufficient intake
of essential nutrients for red blood cell production (iron, B12 or folic acid), chronic diseases …